Evidence map›Paper›PMID 34154611›Full record

ArticleJournal of experimental & clinical cancer research : CR2021

Integrated multi-omics analyses on patient-derived CRC organoids highlight altered molecular pathways in colorectal cancer progression involving PTEN.

Marta Codrich, Emiliano Dalla, Catia Mio, Giulia Antoniali, Matilde Clarissa Malfatti, Stefania Marzinotto, Mariaelena Pierobon, Elisa Baldelli, Carla Di Loreto, Giuseppe Damante and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Marta Codrich *Laboratory of Molecular Biology and DNA Repair, Department of Medicine, University of Udine, Piazzale M. Kolbe 4, 33100, Udine, Italy.
Emiliano Dalla *Laboratory of Molecular Biology and DNA Repair, Department of Medicine, University of Udine, Piazzale M. Kolbe 4, 33100, Udine, Italy.
Catia MioInstitute of Medical Genetics, Department of Medicine, University of Udine, 33100, Udine, Italy.
Giulia AntonialiLaboratory of Molecular Biology and DNA Repair, Department of Medicine, University of Udine, Piazzale M. Kolbe 4, 33100, Udine, Italy.
Matilde Clarissa MalfattiLaboratory of Molecular Biology and DNA Repair, Department of Medicine, University of Udine, Piazzale M. Kolbe 4, 33100, Udine, Italy.
Stefania MarzinottoPiattaforma Specializzata Centro Servizi e Laboratori, Area Biologia Molecolare, Colture Cellulari e Supporto, Azienda Sanitaria Universitaria Friuli Centrale, 33100, Udine, Italy.
Mariaelena PierobonSchool of Systems Biology, Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, 20108, USA.
Elisa BaldelliCenter for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, 20108, USA.
Carla Di LoretoPathology Unit, Department of Medicine, University of Udine, 33100, Udine, Italy.
Giuseppe DamanteInstitute of Medical Genetics, Department of Medicine, University of Udine, 33100, Udine, Italy.
Giovanni TerrosuGeneral Surgery and Transplantation Unit, Department of Medicine, University of Udine, 33100, Udine, Italy.
Carlo Ennio Michele PucilloLaboratory of Immunology, Department of Medicine, University of Udine, 33100, Udine, Italy.
Gianluca TellLaboratory of Molecular Biology and DNA Repair, Department of Medicine, University of Udine, Piazzale M. Kolbe 4, 33100, Udine, Italy. gianluca.tell@uniud.it.
University of Udine · ITGeorge Mason University · US

Funding

Associazione Italiana per la Ricerca sul Cancro IG19862European Regional Development Fund Program PRECANMED ITAT1009 CUP G22F16000890006
6 · The paper itself

Abstract

backgroundColorectal cancer (CRC) represents the fourth leading cause of cancer-related deaths. The heterogeneity of CRC identity limits the usage of cell lines to study this type of tumor because of the limited representation of multiple features of the original malignancy. Patient-derived colon organoids (PDCOs) are a promising 3D-cell model to study tumor identity for personalized medicine, although this approach still lacks detailed characterization regarding molecular stability during culturing conditions. Correlation analysis that considers genomic, transcriptomic, and proteomic data, as well as thawing, timing, and culturing conditions, is missing.

methodsThrough integrated multi-omics strategies, we characterized PDCOs under different growing and timing conditions, to define their ability to recapitulate the original tumor.

resultsWhole Exome Sequencing allowed detecting temporal acquisition of somatic variants, in a patient-specific manner, having deleterious effects on driver genes CRC-associated. Moreover, the targeted NGS approach confirmed that organoids faithfully recapitulated patients' tumor tissue. Using RNA-seq experiments, we identified 5125 differentially expressed transcripts in tumor versus normal organoids at different time points, in which the PTEN pathway resulted of particular interest, as also confirmed by further phospho-proteomics analysis. Interestingly, we identified the PTEN c.806_817dup (NM_000314) mutation, which has never been reported previously and is predicted to be deleterious according to the American College of Medical Genetics and Genomics (ACMG) classification.

conclusionThe crosstalk of genomic, transcriptomic and phosphoproteomic data allowed to observe that PDCOs recapitulate, at the molecular level, the tumor of origin, accumulating mutations over time that potentially mimic the evolution of the patient's tumor, underlining relevant potentialities of this 3D model.

Indexed as

Colorectal NeoplasmsDisease ProgressionExome SequencingHumansOrganoidsProteomicsPTEN PhosphohydrolasePTEN PhosphohydrolasePTEN protein, humanColorectal cancerOrganoidsPTENRNA-seqWhole exosome sequencing

Identifiers

PMID34154611
PMCPMC8215814
OpenAlexW3173339746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.